ARMT

ARMT performs integrative analysis of RNA-seq, transcriptomic, and genomic data using Gene Set Variant Analysis (GSVA) to characterize molecular features and prognostic signals in cancer.

Key Features:

• Integrative Analysis: ARMT combines Gene Set Variant Analysis (GSVA) with other molecular characteristic analyses and prognostic features to provide multi-layered interpretation of RNA-seq data.
• Comprehensive Molecular Characterization: ARMT analyzes single genes and gene sets leveraging transcriptome and genomic data for detailed molecular profiling.
• Prognostic Insights: ARMT incorporates prognostic characteristics to identify potential biomarkers and therapeutic targets.
• Pathway Analysis: ARMT bridges gene-level and pathway-level analyses to support pathway enrichment and functional interpretation.
• Computational Efficiency: ARMT enables rapid processing of RNA-seq data.

Scientific Applications:

• Cancer Research: ARMT supports investigation of tumorigenesis and progression and the identification of biomarkers and therapeutic targets through integrative RNA-seq and genomic analyses.
• Transcriptomic Studies: ARMT facilitates detailed transcriptome analysis across cancer types and stages using gene- and gene-set level approaches.
• Pathway Analysis: ARMT enables pathway enrichment and interpretation by linking gene expression patterns to biological pathways.

Methodology:

ARMT processes RNA-seq data and integrates Gene Set Variant Analysis (GSVA) with transcriptomic and genomic data analysis for multi-layered examination of molecular characteristics.